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Nuclear RNA decay factors are involved in many different pathways including rRNA processing, snRNA and snoRNA
biogenesis, pre-mRNA processing, and the rapid decay of cryptic intergenic transcripts. In contrast to its yeast
counterpart, the mammalian nuclear decay machinery is largely uncharacterized. Here we report interactions of several
putative components of the human nuclear RNA decay machinery, including the TRAMP complex protein Mtr4 and the
nuclear exosome constituents PM/Scl-100 and PM/Scl-75, with components of the U4/U6.U5 tri-snRNP complex required
for pre-mRNA splicing. The tri-snRNP component Prp31 interacts indirectly with Mtr4 and PM/Scl-100 in a manner that is
dependent on the phosphorylation sites in the middle of the protein, while Prp3 and Prp4 interact with the nuclear decay
complex independent of Prp31. Together our results suggest recruitment of the nuclear decay machinery to the
spliceosome to ensure production of properly spliced mRNA.
Introduction
Nuclear machinery not only synthesizes and processes several
different types of coding and non-coding RNA molecules, but
also ensures production of functionally competent RNAs by
selective degradation of aberrant species. More specifically, the
nuclear RNA degradation apparatus is known to participate in
the proper processing of snRNAs, snoRNAs,
1 and rRNAs,
2,3 as
well as in the decay of cryptic transcripts.
4 Moreover, it plays
crucial roles in gene silencing




Two macromolecular complexes, the Trf4/Air2/Mtr4 Poly-
adenylation (TRAMP) complex and the nuclear exosome, con-
tribute both to these processing events and to nuclear RNA
surveillance.
10,15-19 Many non-coding RNAs are generated by
endonucleolytic cleavage, followed by 3'-polyadenylation and
processing of the polyadenylated precursor.
1 The polyadenylation
(TRAMP) complex that marks RNAs for degradation or process-
ing consists of a noncanonical poly(A) polymerase (Trf4/Trf5), a
Zn knuckle-containing RNA binding protein (Air1/Air2), and an
RNA helicase Mtr4.
20,21 The nuclear exosome that is responsible
for degradation or processing contains a nuclear-specific subunit
Rrp6 (PM/Scl-100 in humans) in addition to the nine-subunit
exosome core.
22-24 While Rrp6 is exclusively localized in the
nucleus in Saccharomyces cerevisiae, the human homolog PM/Scl-
100 is predominantly nuclear with a minor fraction present in the
cytoplasm.
25,26 Mutations in yeast factors associated with RNA
splicing (Prp2), with splicing and export (Sub2), with transcrip-
tion (THO), and with polyadenylation (Rna14, Rna15) have
revealed a critical role for the nuclear exosome-specific subunit
Rrp6 in counteracting the generation of aberrant messages
produced in these mutant cells.
7,8,11,14
Communication between all these nuclear events—transcription,
splicing, cleavage, polyadenylation, and nuclear RNA degradation—
is pivotal to the formation of functional eukaryotic RNAs.
27 The
complex steps of splicing must be strictly orchestrated in order
to avoid creating aberrant messages. Adding an extra layer of
complexity is alternative splicing in higher eukaryotes, which
plays a regulatory role in generating mRNAs in a tissue-specific
manner and can be important in disease (for review see ref.28).
Although there are relatively few genes that undergo splicing in
S.cerevisiae, a connection between the splicing and the nuclear
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decay machineries has been established. Bousquet-Antonelli etal.
showed that levels of pre-mRNA remained low after disrupting
splicing, either with a temperature-sensitive allele of Prp2 (a
splicing factor required for the first transesterification step) or
with a 3'-splice site mutation in the intron.
8 However, inhibition
of degradation by the nuclear exosome resulted in accumulation
of both pre-mRNAs and spliced RNAs, suggesting a competition
between splicing and degradation of pre-mRNAs.
In vertebrates, communication between splicing and the
nuclear degradation machinery is likewise expected, but no




S.pombe, as is the exosome, including the nuclear-specific sub-
unit Rrp6(PM/Scl-100).
10,25,32 Yet, both the TRAMP complex
and the exosome are poorly characterized in mammalian cells,
and the current literature reports only a few investigations of the
Trf4-mediated TRAMP complex and its connection with the
Rrp6-mediated exosome complex.
2,33,34 Two human proteins,
Trf4-1 (pols) and Trf4-2 (papd5), share 37% identity and 56%
similarity with the yTrf4 protein. Recently, Shcherbik etal.
identified a role of papd5 in degradation of transcripts generated
by RNA polymeraseI.
34 However, the composition of the
mammalian complexes that include these proteins is yet to be
reported.
We set out to characterize the human homolog of the yeast
TRAMP complex, which may play a role in degradation of
aberrant RNAs in the nucleus of mammalian cells. Here we
report interactions of the nuclear decay factors Mtr4 and PM/
Scl-100 (and -75) with tri-snRNP-associated proteins in HeLa
and HEK293 cells. Our results suggest a possible mechanism
for recruitment of the nuclear decay machinery to splicing
complexes.
Results
Mammalian homologs of TRAMP complex components Trf4-1
and Mtr4 associate with the tri-snRNP protein Prp31. To isolate
factors associated with human Trf4 proteins, a FLAG-tagged
Trf4-1 was expressed in HEK293 cells, followed by extract
preparation and immunoprecipitation with anti-FLAG antibody
in the presence of ribonuclease (RNase) A. Immunoprecipitated
proteins were eluted using FLAG peptide and were subjected to
LC-MS/MS (TableS1). Surprisingly, among many proteins that
may be non-specific background (for example, Gemin4 in
Fig.1A), we identified a tri-snRNP-specific splicing factor,
Prp31, whose enrichment was verified by western blot analysis
of the immunoprecipitate (IP) (Fig.1A). Prp31 is part of the
U4/U6 complex and plays an important role in the stability and
integrity of the spliceosome.
35-38 It is also linked to autosomal
dominant retinitis pigmentosa, a genetic eye condition that
progressively leads to incurable blindness.
39
Finding a splicing factor associated with a putative nuclear
RNA decay factor suggests potential regulation of RNA pro-
cessing. Since we discovered the presence of a tri-snRNP protein
Prp31 in the Trf4-1 coimmunoprecipitate, we sought to establish
whether this interaction serves to recruit the nuclear decay
machinery to the spliceosome. Therefore, we asked if other
members of the nuclear RNA decay complex (Mtr4) or of the
exosome machinery (PM/Scl-100) also associate with Prp31.
Immunoprecipitation of Prp31 using an anti-Prp31 antibody
(mouse polyclonal, Abnova) immunoprecipitated a small fraction
of Prp31 from the nuclear extract and resulted in modest but
clear coimmunoprecipitation of Mtr4 with RNaseA treatment
(Fig.1B). In contrast, a rabbit polyclonal antibody
35 raised
against the C-terminus (aa484–497) of Prp31 failed to
Figure1. Human Trf4-1 and Mtr4 interact with the tri-snRNP component Prp31. (A) western blot analysis of proteins immunoprecipitated from nuclear
extract of HEK293T cells expressing FLAG-tagged Trf4-1 using anti-FLAG agarose beads; the blot was probed with anti-Prp31 antibody (rabbit).
(B) Anti-Prp31 antibody (Abnova, mouse polyclonal) was used for immunoprecipitation from HeLa nuclear extract after RNaseA treatment. The IP was
run on SDS-PAGE, transferred and probed with anti-Mtr4 antibody (top panel) and rabbit anti-Prp31 (Lührmann laboratory) (bottom panel).
(C) Immunoprecipitation was performed from 50 ml nuclear extract using rabbit anti-Prp31 or anti-Mtr4 (Novus Biologicals, NB100–1575) antibody after
treatment with RNase A (100 ng/ml). Alkaline phosphatase (5U, FastAP, Fermentas) was added to the washed IP sample according to the manufacturer’s
protocol, followed by further washing to remove disengaged proteins. The IPs were western blotted with anti-Mtr4 or rabbit anti-Prp31 antibody.
Lanes 3–5, which were probed with anti-Prp31, show a shorter exposure of the same blot as in lanes 1–2 and 6–9.
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coimmunoprecipitate Mtr4 (Fig.1C, lanes4 and5; for details see
below). A reverse IP of Mtr4 from nuclear extract using an anti-
Mtr4 antibody in the presence of RNaseA, followed by probing
for Prp31 revealed low intensity bands of slightly slower mobility
than the bulk of Prp31, which partially overlaps with antibody
heavy chain (Fig.1C, lanes 7–9). These slower migrating bands
could reflect posttranslationally modified Prp31, which carries
several putative phosphorylation sites (www.phosphosite.org/
proteinAction.do?id=8981&showAllSites=true) (Fig.3). Recently
Schneider et al. thoroughly characterized some of these phos-
phorylation sites on Prp31.
37 Treatment of the extract with
alkaline phosphatase prior to immunoprecipitation with anti-
Mtr4 modestly reduced the intensity of the upper band (25%
decrease) in the Prp31 blot (Fig.1C, lane8).
Prp31 interacts with both Mtr4 and PM/Scl-100 and the
interaction depends on the phosphorylation sites of Prp31.
Since the major band of endogenous Prp31 runs very close to
the antibody heavy chain and is therefore difficult to visualize,
we expressed C-terminally FLAG-tagged Prp31 in HEK293 cells
and performed coimmunoprecipitations after formaldehyde
crosslinking of cells to stabilize weak interactions.
40,41 Immuno-
precipitation and washes were performed using radioimmuno-
precipitation assay (RIPA) buffer along with RNaseA treatment.
Mtr4 coimmunoprecipitated with FLAG-tagged Prp31 even in
the absence of formaldehyde (Fig.2, lane8), indicating that the
inability of rabbit anti-Prp31 to coimmunoprecipitate Mtr4 is
not simply due to a particularly weak interaction between Mtr4
and Prp31. Moreover, FLAG-tagged Prp31 coimmunoprecipi-
tated the exosome subunit PM/Scl-100 (Rrp6), which is possibly
associated through Mtr4,
42 even in the absence of formaldehyde
crosslinking (Fig.2, lanes7 and8). In contrast, Prp6, a U5-
associated protein that interacts directly with Prp31,
35 was present
at much higher levels in the anti-FLAG IP after formaldehyde
treatment (compare lanes7 and8). Likewise, visualization of the
PM/Scl-75 component of the exosome in the FLAG-tagged
Prp31 IP was dependent on formaldehyde (lanes7 and8). Even
though the interactions of Prp6 and PM/Scl-75 seem weak, their
presence suggests involvement of mature and functionally relevant
complexes in this association. As a control, we used a FLAG-
tagged protein with known nuclear localization, METTL1,
which was unable to pull down Mtr4, Prp6, PM/Scl-100, or
-75 (lane 6).
After confirming the interaction between Prp31 and Mtr4,
we wanted to establish whether Mtr4 binding is specific for a
posttranslationally modified form of Prp31. Since Prp31 has
multiple potential phosphorylation sites, we introduced mutations
into each cluster of sites in two Prp31 variants deleted at the
C-terminus (aa1-483 and 1-438, Fig.3A, top). Specifically, we
first generated the truncated Prp31 (aa1-483) to ask whether
the antibody-binding surface of Prp31 located in the C-terminus
between aa484 and aa497
35 is required for the association
of Prp31 with Mtr4. This would explain the lack of Mtr4
coimmunoprecipitation with rabbit anti-Prp31 raised against this
epitope (Fig.1). Second, we created a further deletion (leaving
aa1-438) of the C-terminus to remove several putative phospho-
rylation sites and also generated alanine mutations to disrupt
other sites: mutant 1 (mut1) carries alanine mutations at sites
205, 273, and 275, while mutant 2 (mut2) has additional
mutations to alanine in residues 439, 440, and 455. Mutants
1 and 2 were created in deletion mutant 1-483 (483mut1 and
483mut2), and mutant 1 was generated in the 1-438 (438mut1)
truncated Prp31 (Fig.3A).
Figure3A shows that both Prp31 deletion mutants (483 and
438aa long) bind Mtr4 comparably to the wild-type protein
(compare lanes 10 and 13 with lane9), suggesting that neither
the antibody binding site (aa484-497) nor the C-terminal
phosphorylation sites (aa439-455) contribute to Mtr4 binding.
A similar profile was obtained for PM/Scl-100 binding (Fig.3A).
However, mutations of the phosphorylation sites in the middle
of the 483aa truncated protein (Y205A, Y273A, Y275A) resulted
in diminished binding of Mtr4 (lane11), suggesting that
phosphorylation of these Prp31 residues strengthens the inter-
action with Mtr4. As expected from lane 13, additional mutations
in the C-terminal phosphorylation sites (S439A, T440A, T445A)
did not hinder the binding capacity further (compare lanes 11
and12). Similar to the mutations in the 483aa protein, muta-
tions of aa205, 273, and 275 in the 438aa Prp31 protein reduced
binding of Mtr4, but even more efficiently (lane14). We there-
fore conclude that the phosphorylation sites in the middle of the
Prp31 molecule contribute significantly to its interaction with
Figure2. Prp31 forms a complex with both Mtr4 and PM/Scl-100.
FLAG-tagged Prp31 was expressed in HEK293 cells and cell extracts were
prepared with or without prior formaldehyde crosslinking using RIPA
buffer followed by sonication. Anti-FLAG M2 conjugated agarose beads
(Sigma) were used for immunoprecipitation followed by western blot
analysis for the tri-snRNP-associated protein Prp6 and the exosome-
associated proteins PM/Scl-100, PM/Scl-75 and Mtr4, as indicated
on the right. * represents an unknown non-specifically reacting protein.
Both lanes 2 and 3 and lanes 6 and 7 were initially separated by one lane,
which was removed for presentation.
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Figure3. Interaction between Prp31 and Mtr4 is dependent on the phosphorylation sites of Prp31. (A, top) FLAG-tagged mutants of hPrp31,
which include two different deletions at the C-terminus (aa1–483 and aa1–438), as well as the indicated amino acid substitutions at specific positions.
(A, bottom) Binding of Prp31 to Mtr4 depends on putative phosphorylation sites in the middle of Prp31. Each Prp31 mutant was individually expressed
in HEK293 cells followed by lysate preparation in RIPA buffer followed by sonication. FLAG-tagged Prp31 mutants and associated proteins were selected
on anti-FLAG M2 agarose beads followed by western blotting to identify the interacting partners indicated on the right. A longer exposure did not reveal
significant binding of Mtr4 and PM/Scl-100 in lane 14 (data not shown). (B) Relative binding of PM/Scl-100 and Mtr4 to each FLAG-tagged Prp31 protein
is graphed. The western blot was analyzed using Image J; bound fractions of Prp31, PM/Scl-100, and Mtr4 proteins were normalized to their respective
inputs, and binding data were plotted for the normalized PM/Scl-100 and Mtr4 relative to the normalized FLAG proteins in the IP lanes. Results are
presented as an average of two experiments except for the 438aa Prp31 determination, which was from one experiment.
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Mtr4 and PM/Scl-100. Quantification of the western blot data
are shown in Figure3B.
Mtr4 associates with other components of the tri-snRNP
independent of Prp31. Since Prp31 is part of the U4/U6.U5
tri-snRNP, we asked whether Mtr4 interaction extends to other
components of the tri-snRNP complex. We used available anti-
bodies to probe the interactions of endogenous (rather than
tagged) tri-snRNP proteins (Prp4 and Prp6) with Prp3, Prp31,
Mtr4, PM/Scl-100, and PM/Scl-75 in nuclear extract treated
with RNaseA (Fig.4A). The anti-Prp3 IP contained significant
amounts of Mtr4 (Fig.4A, lane4). Similarly, anti-Mtr4 appears
to coimmunoprecipitate Prp4 (Fig.4B, lane4), a conclusion that
is confirmed below (see Fig.5). In contrast, none of the proteins
detectably coimmunoprecipitated Prp6 (Fig.4A), consistent with
Prp6’s weak interaction with the Mtr4-Prp31 complex in the
absence of formaldehyde (Fig.2, lane8). These results argue that
Mtr4 associates with at least two other proteins of the U4/U6
complex (Prp3 and Prp4) and not just with a fraction of Prp31
that is not part of the tri-snRNP. We further assessed the
association of snRNAs with these complexes (Fig.4C). The anti-
Mtr4 IP in the absence of RNaseA showed enrichment of U6
snRNA over U2, suggesting the presence of tri-snRNP rather than
the whole spliceosome.
To provide mechanistic insight into the
recruitment of the nuclear exosome complex
to the spliceosome, we sought to identify the
direct interaction partner(s) of Mtr4 using
bacterially-expressed Mtr4 and
35S-Met radi-
olabeled Prp31 and Prp4 proteins synthesized
in reticulocyte lysates. Even though it was dif-
ficult to generate full-length GST-tagged Mtr4 protein (because
of stalled translation of the protein even in Rosetta cells), we were
able to verify binding of Prp4 to the GST-Mtr4 partial proteins
(Fig.5, lane6).
35S-labeled Prp31 did not bind to the mixture
of GST-Mtr4 products (Fig.5, lane5), which is compatible with
the results of the depletion experiment shown in Figure6.
However, since the comparable experiment with Prp3 did not
reveal binding to GST-Mtr4 above the background level (data
not shown), we cannot rule out additional direct interactions
with other di-snRNP proteins.
To determine whether Mtr4’s interaction with Prp3 and Prp4
proteins of the U4/U6 di-snRNP complex depends on Prp31, we
performed immunoprecipitation of Prp3 from Prp31-depleted
nuclear extract. Prp3 was chosen since it showed more efficient
coimmunoprecipitation of Mtr4 than the other di-snRNP
proteins (Fig.4A and data not shown). At low salt concentration
(150–200mM KCl) the U4/U6.U5 tri-snRNP is stable and
retains all its protein and RNA components. But at higher
concentrations (300–400mM) of KCl, the U5 snRNP dissociates
from the U4/U6 complex; moreover, Prp31 dissociates from the
U4/U6 di-snRNP.
35,43 We performed immunodepletion of Prp31
at 700mM NaCl where Prp31 can be immunoprecipitated
alone.
35,44 The salt concentration was then adjusted back to
Figure4. Mtr4 associates with tri-snRNP proteins Prp3 and Prp4. (A) Coimmunoprecipitation
reveals interaction of Mtr4 with Prp3. Antibodies against several Prp proteins and decay
factors were used for IP from RNase-treated HeLa nuclear extract followed by western blot
analysis. (B) Prp4 associates with Mtr4 in a similar IP conducted using anti-Mtr4 and probing
the precipitate with anti-Prp4. Lane 4 is from the same gel as lanes 1–3, with the same
exposure time. (C) U6 and U2 snRNAs were analyzed using quantitative RT PCR of Mtr4 IPs
performed without RNase treatment. Results are presented as an average of two experiments.
Figure5. Prp4 interacts with Mtr4. Bacterially
expressed GST-Mtr4 polypeptides were isolated on
glutathione beads and incubated with
35S-Met
radiolabeled Prp31 or Prp4 transcribed and
translated (lanes 1 and 2) in reticulocyte lysate
(Promega). Bound fractions were washed and
fractionated by SDS-PAGE followed by autoradio-
graphy. Prp4 showed significant binding to GST-
Mtr4 compared with GST. In this experiment, Prp31
consistently exhibited two bands (lane 1), which
could be either a stalled or phosphorylated product.
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150mM NaCl, a condition in which Prp4 and Prp3 maintain
their interaction.
43 The resulting Prp31-depleted supernatant, as
well as a mock-depleted supernatant, were subjected to immuno-
precipitation by anti-Prp3 antibody. In both cases, Mtr4 appeared
(Fig.6, right panel, lanes 2 and 4, arrow), running just below the
non-specific band present in the preimmune serum. This result
confirms that Prp3 associates with Mtr4 even in the absence of
Prp31. In combination with Figure5, the data suggest that Mtr4
is possibly associated with U4/U6 snRNP components through
Prp4, while its interaction with Prp3 and Prp31 could be through
Prp4 or through other TRAMP complex components.
Discussion
We have demonstrated that components of the nuclear decay
machinery, Mtr4 and PM/Scl-100, interact with several U4/U6-
associated proteins (Prp31, Prp3, and Prp4) of the tri-snRNP
complex within the spliceosome. These findings suggest a possible
mechanism for recruitment of the decay machinery to the pre-
mRNA processing apparatus to ensure generation of properly
spliced RNA and decay of aberrant transcripts.
Communication between the splicing and decay machineries
was anticipated from genetic interactions observed between the
splicing factor Prp2 and subunits of the exosome in S.cerevisiae.
8
Specifically, whereas a temperature-sensitive allele of Prp2 showed
decreased levels of spliced RNA without an increase in the
unspliced precursor at the non-permissive temperature, when
combined with a deletion of Rrp6, unspliced precursor levels
increased. This result suggested that unspliced precursors
generated because of a defect in splicing were being degraded
by the nuclear exosome complex.
8 Likewise, defects in the
THO/Sub2 complex, which is involved in mRNP biogenesis
and export, have been reported to result in degradation of a
specific pool of mRNAs by a pathway that includes both the
TRAMP and exosome complexes.
11 Finally, defects in mRNA
cleavage and polyadenylation likewise result in decay of long
read-through transcripts by an Rrp6-dependent mechanism.
7,12
Our results offer a possible scenario for recruiting the exosome
to the mammalian spliceosome through the U4/U6.U5 tri-
snRNP complex, adding to our understanding of the mammalian
decay process. Prp31 exhibited an RNaseA insensitive association
with Mtr4 (Figs.1–3). This interaction does not seem to be
direct and is not itself principally responsible for the association
between the tri-snRNP and TRAMP complexes since anti-Prp3
antibodies can immunoprecipitate Mtr4 from a Prp31-depleted
extract (Fig.6). Moreover, bacterially expressed GST-Mtr4 binds
in vitro translated Prp4 (Fig.5), suggesting that this is one of the
principal interactions. Interestingly, mutations in three potential
phosphorylation sites (Y205, Y273, and Y275) of Prp31 were able
to disrupt association of Prp31 with Mtr4 significantly. The X-ray
crystal structure of Prp31 shows that residue Y205 does not
interact with the 15.5k protein of the U4 snRNP but is exposed
and could bind some other component.
38 Residues Y273 and
Y275 are located in a loop within a cleft that is in close proximity
to the U4 snRNA binding site; however, the side chains point
away from the U4 RNA. Although the mechanism by which
phosphorylation enhances Prp31 interaction with Mtr4 is not
clear, it is possible that aa 205, 273, and 275 contribute to
stability of the U4/U6 complex and that other proteins of this
complex bridge the interaction of Prp31 with Mtr4. Recent
work from the Lührmann laboratory suggests that phosphoryla-
tion of Prp31 by the Prp4 kinase induces assembly and
stabilization of the spliceosomal B complex.
37 Our work supports
the idea that even though Mtr4 directly binds to the tri-snRNP
through Prp4, phosphorylated Prp31 enhances the stability of the
interaction between the spliceosome and the exosome.
Prp31 is evolutionarily conserved and the human protein
shares 25% identity and 60% similarity with its homolog in
budding yeast.
35 Interestingly, the Prp31 homolog in S.cerevisiae
is conserved in some residues including Y273 but lacks many
other tyrosine, threonine, and serine residues present in hPrp31.
Budding yeast also lacks the Prp4 kinase that is known to
be responsible for phosphorylating both Prp31 and Prp6 in
humans.
37 Thus, even though our Y205A, Y273A, and Y275A
triple mutant of human Prp31 is significantly deficient in binding
Mtr4, in budding yeast there must exist an alternative way of
recruiting the exosome complex. Perhaps with the lower com-
plexity of splicing in yeast, fewer contacts are needed between
the decay and the splicing machineries.
Figure6. Mtr4 associates with tri-snRNP proteins independent of Prp31.
Anti-Prp3 coimmunoprecipitates Mtr4 from extracts lacking Prp31. Prp31
was first immunodepleted from nuclear extract and the depleted extract
was subjected to immunoprecipitation by anti-Prp3 antibody. Left panel:
Immunodepletion was verified by checking with anti-Prp31 (bottom)
and anti-Mtr4 (top). Right panel: Immunoprecipitated proteins were
analyzed by western blotting with anti-Mtr4 antibody. The arrow
indicates the position of Mtr4 in lanes 2 and 4, running just below
the non-specific band appearing in all lanes. The smear above the Mtr4
band present in both control and Prp3 IP lanes (lanes 1–4) was
consistently present when high salt conditions were used during the IP.
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Mass spectrometric analysis of spliceosomal proteins at various
stages has demonstrated recruitment of Mtr4 to the B complex
and its continuous association with the C complex (supple-
mentary data, ref.43). The presence of exosome subunits in
purified spliceosomes has also been reported [supplementary data,
ref.48]. Since activation of the spliceosomalB complex results in
the dissociation of many U4/U6-associated proteins, including
Prp4, Prp3, and Prp31, the presence of Mtr4 in the C complex
suggests that its association with the active spliceosome is achieved
through some other constituent(s), possibly hnRNPs.
45 Whereas
the tri-snRNP may act as the platform for initial recruitment of
the nuclear exosome-mediated decay complex to spliceosomes,
other proteins such as transcription factors can cotranscriptionally
recruit the nuclear exosome to a pre-mRNA. For example,
Andrulis etal. demonstrated interactions between the nuclear
exosome subunits dRrp6 and dSpt6, elongation factor dSpt5, and
RNA polymerase II in D. melanogaster.
46 Using Chironomus and
Drosophila, Hessle etal. showed that the core exosome subunit
Rrp4 is associated with polytene chromosomes and that this
association is dependent on hnRNP M.
45
Observations that the exosome can interact with multiple
machineries suggest that production of a fully functional mRNA
may be ensured through several different checkpoints. The
exosome makes several contacts with the transcription and RNA
processing machineries, but whether these interactions are
mediated by the TRAMP complex is unknown. Our results
show that both the TRAMP component Mtr4 and the exosome
subunit PM/Scl-100 (and -75) exhibit similar binding interac-
tions with the U4/U6 complex. In addition, we cannot rule out
the possibility that multiple members of the TRAMP complex
make separate contacts with one or more tri-snRNP components.
Our mass spectrometric analysis was unable to detect any Mtr4
in an anti-Trf4-1 IP. The absence of Mtr4 may be due to
technical reasons, as evidenced by the inconsistent presence of
exosome components in the spliceosome analyzed by mass
spectrometry.
47 Our understanding is limited by the absence of
a fully-characterized human TRAMP complex. Further work
will be necessary to understand the contribution of different
Trf4 homologs and their isoforms to functional TRAMP com-
plexes, and to the stability and integrity of these complexes in the
absence of an RNA substrate.
It will be interesting to learn how and when the decay proteins
dissociate after completion of a splicing event. Their association
with the splicing machinery may simply reflect a coupled process
whereby newly excised introns are rapidly degraded. Communi-
cation between cytoplasmic nonsense-mediated decay and alterna-
tive splicing is one avenue for achieving proper gene expression.
26
Since the majority of mammalian transcripts are regulated by
alternative splicing, the role of nuclear decay factors in deter-
mining the correct splice variant may be another important aspect
of surveillance.
Materials and Methods
Plasmids and cloning. Primers used to generate cDNAs for
Trf4-1, Mtr4, and Prp31 are listed in TableS2 along with the
primers that were used for introducing mutations in Prp31.
hTrf4-1 cDNA was generated by primers AN101 and AN102 and
was introduced into the HindIII site of pcDNA3.1 carrying a
FLAG tag upstream. METTL1-FLAG is described in Alexandrov
etal.
48 Primers AN189 and AN190 were then used to generate
Prp31 cDNA with a C-terminal FLAG sequence, which was
inserted in the BamHI-XhoI site. AN202, AN203, AN204, and
AN205 were used to introduce the Y205A, Y273A, and Y275A
mutations (mut1), whereas AN206, AN207, AN210, and AN211
were used to generate additional S439A, T440A, and S455A
mutations (mut2) into the C-terminally FLAG-tagged Prp31 by
site-directed mutagenesis. Primers AN189/AN225 and AN189/
AN226 were used to generate truncated Prp31 proteins, aa1–483
and aa1–438. Mtr4 cDNA was generated using AN110 and
AN232 primers and was inserted into the XhoI site of the pGEX-
6P-3 construct (GE Life Healthcare Sciences). Plasmids used for
in vitro transcription/translation of Prp proteins were obtained
from Open Biosystems.
Extract preparation and immunoprecipitation. FLAG-tagged
proteins were expressed in HEK293 cells by transfecting
appropriate plasmids. 48h later, cells were harvested and washed
with ice-cold PBS. Cells were then incubated in 1 packed cell
volume (PCV) of buffer A (10mM Hepes, 1.5mM MgCl2,
100mM KCl, 0.1mM DTT), followed by passage through a
25 5/8G needle attached to a 1ml syringe 8 times. The cell lysate
was centrifuged at 12000g. The supernatant was discarded and
the pellet that contains nuclei was collected. The pellet was
incubated with 2/3 PCV of buffer C (20mM Hepes, 25%
glycerol, 1.5mM MgCl2, 420 mM NaCl, 0.2mM EDTA,
0.1mM DTT, and 1 protease inhibitor cocktail from Calbio-
chem) for 15 min on ice. Finally, the nuclear fraction was
centrifuged at 12000g for 5min and the supernatant collected for
immunoprecipitation. Extract from four 10 cm plates (approxi-
mately 20  10
6 cells) was mixed with 40ml FLAG-M2 beads
(Sigma) for immunoprecipitation for 2–4h at 4°C. Beads were
washed with 20 volumes of wash buffer (20mM Tris pH7.5,
0.5mM MgCl2, 0.5M NaCl, and 0.1%NP-40) 5 times. Proteins
were eluted using 60mg FLAG peptide. LC-MS/MS was analyzed
by the protein core facility at Columbia University Medical
Center.
For formaldehyde cross-linking experiments, approximately
5  10
6 cells (one 90% confluent 10cm plate) were incubated
with 0.1% formaldehyde for 10 min at 37°C. Cells were washed
with ice-cold PBS to eliminate extra formaldehyde and the
cross-linking reaction was quenched with 0.5ml 0.25M glycine
for 5min. The cells were washed twice with ice-cold PBS and
resuspended in RIPA buffer containing protease inhibitor
(Calbiochem) and 1mM DTT. After incubation on ice for
10min, the cell suspension was sonicated 3 times for 10sec at
30% efficiency. The lysate was centrifuged at 10000 rpm for
10min and the supernatant was used for immunoprecipitation.
Proteins were precipitated overnight at 4°C using 20ml FLAG-
M2 beads in the presence of 50mg BSA and 10mg RNaseA. The
IP was washed with 1 ml RIPA buffer 8 times and proteins were
eluted with SDS buffer. Experiments without crosslinking were
done exactly the same way but without formaldehyde and glycine.
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We were able to obtain significant binding between FLAG-
tagged Prp31 and Mtr4 reproducibly only when cell lysates were
prepared in RIPA buffer followed by sonication. An extract
prepared by the milder Dignam protocol failed to show signifi-
cant interaction.
Prp31 immunodepletion. An amount of 40ml Dignam
nuclear extract was adjusted to 700mM NaCl, followed by
immunodepletion using 6mg protein A beads bound to anti-
Prp31 antibody for 2h. Supernatant from the depletion was
incubated with protein A beads without antibody for 30 min.
A mock depletion was performed in parallel using rabbit
preimmune serum. Depleted extract was diluted with buffer D
to bring the final salt concentration to 150mM NaCl. Extract was
divided into two sets for anti-Prp3 and rabbit preimmune serum-
mediated immunoprecipitation using 2.5mg protein A beads.
After 2h, the IP was washed fourtimes with 500ml NET-2
buffer. Proteins were eluted with SDS sample buffer and were run
on an 8% gel followed by probing with anti-Mtr4 antibody.
GST-Mtr4 expression and immunoprecipitation. The GST-
Mtr4 expression plasmid (see Plasmids and cloning) was trans-
formed into Rosetta cells and protein was expressed at 37°C for
3 h following IPTG treatment. Proteins were isolated following
the protocol for the GST expression system (GE Healthcare
Life Sciences) and were purified on 100 ml glutathione beads.
Twenty microliter glutathione bead-bound protein was subse-
quently incubated with 45 ml T7/SP6 reticulocyte lysate-
generated (TNT T7/SP6 Quick Coupled Transcription/
Translation System, Promega)
35S-Met radiolabeled protein from
individual plasmids expressing Prp proteins overnight at 4°C.
Beads were washed with 500 ml IPP150 buffer (150 mM NaCl,
0.1% NP-40, 10 mM Tris pH 8.0) three times, and proteins were
eluted in SDS buffer and run on SDS-PAGE.
RNA analysis. IP was conducted with anti-Mtr4 antibody
on protein A/G beads (Calbiochem) without RNase treatment
followed by DNase treatment and recovery of the RNA using
Trizol (Invitrogen) following the manufacturer’s protocol. This
RNA was subjected to qPCR analysis using primers AN244/
AN245 for U2 and AN246/247 for U6 (TableS2).
Antibodies. Anti-Mtr4 (cat no. 1574, 1575) was obtained from
Novus Biologicals, mouse polyclonal anti-Prp31 (H00026121-
A01) from Abnova, and anti-PM/Scl-75 from Santa Cruz
Biotechnology. Antibodies for Prp3, Prp4, Prp6, and Prp31
(raised against a peptide corresponding to aa 484–497 of
Prp31) were the generous gift of Dr. R. Lührmann (Max-
Planck Institute for Biophysical Chemistry, Goettingen,
Germany). PM/Scl-100 antibody was a gift from Dr. G. Pruijn
(Nijmegen Center for Molecular Life Sciences, Netherlands).
Gemin4 antibody was a gift from Dr. Gideon Dreyfuss
(University of Pennsylvania).
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